$ACT Actavis Inc (ACT) 211.56 +2.88 (+1.38%) Past 5

New Post Public Reply Private Reply Replies (0) Message Board

Mar 11, 2014 at 10:24 AM

$ACT
Actavis Inc (ACT)
211.56 +2.88 (+1.38%)

Past 5 Days
Date Open High Low Last Change % Change Volume
03/11/14 208.97 212.50 207.05 211.56 +2.88 +1.38% 400,561
03/10/14 209.56 212.74 206.49 208.68 -4.50 -2.11% 3,255,100
03/07/14 215.70 216.09 206.48 213.18 -0.77 -0.36% 4,897,500
03/06/14 224.96 225.45 213.88 213.95 -10.60 -4.72% 4,153,900
03/05/14 227.06 227.39 223.73 224.55 -1.57 -0.69% 1,520,100

Historical Highs and Lows
-- Period -- -- High -- -- Low -- -- Percent Change --
5-Day 227.39 on 03/05/14 206.48 on 03/07/14 -6.20% since 03/04/14
1-Month 230.77 on 02/26/14 187.26 on 02/13/14 +10.91% since 02/11/14
3-Month 230.77 on 02/26/14 156.40 on 12/17/13 +32.25% since 12/11/13
6-Month 230.77 on 02/26/14 135.00 on 09/12/13 +56.94% since 09/11/13
12-Month 230.77 on 02/26/14 88.50 on 03/12/13 +140.02% since 03/11/13
Year to Date 230.77 on 02/26/14 166.38 on 01/03/14 +26.26% since 12/31/13

New Highs and Lows
For The Last Made New High Percent From Made New Low Percent From
5-Day 1 time -6.72% 3 times +2.73%
1-Month 7 times -8.09% 2 times +13.27%
3-Month 24 times -8.09% 2 times +35.62%
6-Month 39 times -8.09% 1 time +57.12%
12-Month 61 times -8.09% 1 time +139.67%
Year to Date 17 times -8.09% 2 times +27.49%

Newer

Older

Scroll down for more posts ▼

Top 5 Most Recently Viewed Articles

Microfluidics Market Growth: Insights and Future Trends

Microfluidics Market Overview The global microfluidics market, valued at approximately USD 21.36 billion, is set for impressive growth. Predictions suggest it will reach about USD 32.67 billion by the end of 2029. This significant expansion is a clear indicator of the transformation occurring within diagnostics, life sciences, and pharmaceutical research. Driving Forces...

How a $1000 Investment in Primerica Can Grow Over Time

The Incredible Growth of Primerica Primerica (NYSE: PRI) has truly left a mark in the financial sector, showcasing remarkable performance over the last decade. With an annualized return of 17.97%, it has outperformed the market by 7.08%, demonstrating its strong foundational growth and investment appeal. As of now, Primerica holds a market capitalization of $9.18 billion,...

Illumina Joins Forces with MyOme: A Game Changer in Healthcare

Illumina and MyOme Collaboration Overview Illumina has recently entered into a significant collaboration deal with MyOme, a company specializing in genomic analysis. This partnership isn't just a strategic investment; it's an aerospace-like synergy aimed at transforming how healthcare operates in the United States. With a bold vision, the duo is set to explore innovative...

BlackSky Technology Secures Major Contract Boosting Stock Appeal

BlackSky Technology Gains Momentum After Major Contract Win BlackSky Technology Inc (BKSY) has seen its shares trade higher recently thanks to the remarkable announcement of a five-year contract with the U.S. National Geospatial-Intelligence Agency (NGA). This contract, valued at up to $290 million, will enable BlackSky to leverage its advanced satellite monitoring...

BioXcel Therapeutics to Showcase Innovations at Conference

BioXcel Therapeutics: AI in Medicine BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is making waves in the biopharmaceutical sector using artificial intelligence (AI) to forge new paths in neuroscience medication. The CEO, Vimal Mehta, Ph.D., will take the stage at the highly regarded Canaccord Genuity 45th Annual Growth Conference. This pivotal event will take place in...

$ACT Actavis Inc (ACT) 211.56 +2.88 (+1.38%) Past 5

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles